US FDA declines to approve Minerva Neurosciences' schizophrenia drug

Minerva Neurosciences

27/02/2024 13:11

Feb 27 (Reuters) - Minerva Neurosciences  NERV.O  said
on Tuesday the U.S. Food and Drug Administration has declined to
approve its experimental drug for the treatment of negative
symptoms in patients with schizophrenia.

 (Reporting by Pratik Jain in Bengaluru)
 ((Pratik.Jain@thomsonreuters.com;))